Four subtypes of AD were deduced, each with unique genetic associations and different features in alternative clinical phenotypes as well as cognitive performance; key demographic variables included levels of Aβ and phosphorylated-tau (Table 2). The gene discussed is MAPT; the disease is Alzheimer disease.